Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Imbruvica (ibrutinib) for Chronic Graft Versus Host Disease

drugs.comAugust 03, 2017

Tag: FDA , Chronic Graft Versus Host Disease

PharmaSources Customer Service